Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.
Animals
Atherosclerosis
/ genetics
Cardiovascular Diseases
/ genetics
Disease Models, Animal
Disease Progression
Eating
Enterocytes
/ cytology
Female
Glucagon-Like Peptide 1
/ metabolism
Glucagon-Like Peptide-1 Receptor
/ metabolism
Integrin beta Chains
/ genetics
Intestine, Small
/ cytology
Intraepithelial Lymphocytes
/ metabolism
Male
Metabolic Syndrome
/ genetics
Mice
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
01
12
2017
accepted:
05
12
2018
pubmed:
1
2
2019
medline:
25
7
2019
entrez:
1
2
2019
Statut:
ppublish
Résumé
The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways
Identifiants
pubmed: 30700910
doi: 10.1038/s41586-018-0849-9
pii: 10.1038/s41586-018-0849-9
pmc: PMC6367023
mid: NIHMS1515990
doi:
Substances chimiques
Glp1r protein, mouse
0
Glucagon-Like Peptide-1 Receptor
0
Integrin beta Chains
0
integrin beta7
0
Glucagon-Like Peptide 1
89750-14-1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
115-119Subventions
Organisme : NHLBI NIH HHS
ID : P01 HL131478
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128264
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL135752
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI118692
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Références
Begg, D. P. & Woods, S. C. The endocrinology of food intake. Nat. Rev. Endocrinol. 9, 584–597 (2013).
doi: 10.1038/nrendo.2013.136
Drucker, D. J. The cardiovascular biology of glucagon-like peptide-1. Cell Metab. 24, 15–30 (2016).
doi: 10.1016/j.cmet.2016.06.009
Cerf-Bensussan, N., Bègue, B., Gagnon, J. & Meo, T. The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a β7 subunit associated with a distinctive α chain. Eur. J. Immunol. 22, 273–277 (1992).
doi: 10.1002/eji.1830220140
Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445–456 (2011).
doi: 10.1038/nri3007
Holzmann, B., McIntyre, B. W. & Weissman, I. L. Identification of a murine Peyer’s patch—specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell 56, 37–46 (1989).
doi: 10.1016/0092-8674(89)90981-1
Holzmann, B. & Weissman, I. L. Peyer’s patch-specific lymphocyte homing receptors consist of a VLA-4-like α chain associated with either of two integrin β chains, one of which is novel. EMBO J. 8, 1735–1741 (1989).
doi: 10.1002/j.1460-2075.1989.tb03566.x
Parker, C. M. et al. A family of β
doi: 10.1073/pnas.89.5.1924
Gorfu, G., Rivera-Nieves, J. & Ley, K. Role of β7 integrins in intestinal lymphocyte homing and retention. Curr. Mol. Med. 9, 836–850 (2009).
doi: 10.2174/156652409789105525
Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570–586 (2017).
doi: 10.1016/j.cell.2017.04.004
Johnson, A. M. & Olefsky, J. M. The origins and drivers of insulin resistance. Cell 152, 673–684 (2013).
doi: 10.1016/j.cell.2013.01.041
Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111–2117 (2011).
doi: 10.1172/JCI57132
Odegaard, J. I. & Chawla, A. The immune system as a sensor of the metabolic state. Immunity 38, 644–654 (2013).
doi: 10.1016/j.immuni.2013.04.001
Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161–166 (2013).
doi: 10.1126/science.1230719
Swirski, F. K. et al. Ly-6C
doi: 10.1172/JCI29950
Hilgendorf, I. & Swirski, F. K. Making a difference: monocyte heterogeneity in cardiovascular disease. Curr. Atheroscler. Rep. 14, 450–459 (2012).
doi: 10.1007/s11883-012-0274-8
Berlin, C. et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185–195 (1993).
doi: 10.1016/0092-8674(93)90305-A
Wagner, N. et al. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 382, 366–370 (1996).
doi: 10.1038/382366a0
Schön, M. P. et al. Mucosal T lymphocyte numbers are selectively reduced in integrin α
pubmed: 10352281
Uehara, S., Grinberg, A., Farber, J. M. & Love, P. E. A role for CCR9 in T lymphocyte development and migration. J. Immunol. 168, 2811–2819 (2002).
doi: 10.4049/jimmunol.168.6.2811
Lycke, N. Y. & Bemark, M. The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol. 10, 1361–1374 (2017).
doi: 10.1038/mi.2017.62
Fagarasan, S. & Honjo, T. Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol. 3, 63–72 (2003).
doi: 10.1038/nri982
Baggio, L. L. & Drucker, D. J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131–2157 (2007).
doi: 10.1053/j.gastro.2007.03.054
Kahles, F. et al. GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering. Diabetes 63, 3221–3229 (2014).
doi: 10.2337/db14-0100
Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016).
doi: 10.1056/NEJMoa1603827
Marso, S. P. et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834–1844 (2016).
doi: 10.1056/NEJMoa1607141
Yusta, B. et al. GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes 64, 2537–2549 (2015).
doi: 10.2337/db14-1577
Lamont, B. J. et al. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J. Clin. Invest. 122, 388–402 (2012).
doi: 10.1172/JCI42497
Arakawa, M. et al. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 59, 1030–1037 (2010).
doi: 10.2337/db09-1694
Nagashima, M. et al. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia 54, 2649–2659 (2011).
doi: 10.1007/s00125-011-2241-2
Kim, M. et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat. Med. 19, 567–575 (2013).
doi: 10.1038/nm.3128